Tuesday, 9 August 2016

Reporting Adverse Events Linked to Your Implants

Adverse event reporting is supposed to help the health & safety regulators identify potential problems. Not enough reports were being made all the time PIP were being used. In the UK the MHRA say they have been and will continue to monitor adverse event reports from PIP women. Most women have no idea they are able to report adverse events linked with their implants. But if we dont report our bleeds, ruptures, our lymph node surgeries and symptoms the MHRA and the government will continue to ignore us and our symptoms. 
If you have experienced an adverse effect you associate with your PIP implants, please report them and ask your GP and/or surgeon to do the same. 
Lets do it everyone! Report Yours!  ♡
♥ Together we can make a difference!
In the UK Report Yours to MHRA using this link
In France report adverse events to ANSM
In Australia report adverse events to TGA
In Germany report adverse events to Bfarm
In the USA report adverse events to FDA
In Sweden report adverse events to MPA
Please refer to your Medical Devices Regulatory authority if your country is not shown here.

Saturday, 9 April 2016

Dear Emily❊

“More than 100,000 women and their families in the European Union have been affected by the PIP fraud,
I am one of these women, this is my story...”

PIP Action Campaign made a complaint to the EU Ombudsman regarding the treatment of the women affected by PIP implants. It is clear that the European Commission is not responding to the PIP crisis with honesty, credible science or compassion.

We are encouraging all women affected by PIP implants to write to Emily O’Reilly the EU Ombudsman with details of their own personal stories and experiences of PIP.

We want to let the authorities know the extent to which the current policy has added to the stress and horror of PIP for each and every one of us.

We would like everyone affected to take part and add their voice. Of course, the more women who write the better.

We know that behind every PIP implant there is a broken heart. This is why each “Dear Emily” letter will be a painful, emotional and a courageous act.

But we hope it will make a difference Dear Emily.

Lets try it and see!
Full details of PIP Action Campaign’s complaint to the Ombudsman, reference 174/2015/FOR, can be found on the Ombudsman website. In the final decision Emily O’Reilly stated “The Commission should continue to evaluate new scientific data relating to the safety of PIP implants." And that’s what we want!


To contact Dear Emily, the EU Ombudsman, use the contact form on the Ombudsman website. 
You can type into the form or you can attach a file.
Find the Contact form here:

You will also find web links to the Contact Form on all PIP Action Campaign & PIPSLEAK social networks.

If you have been affected by the PIP fraud you are invited to take part.

Monday, 15 February 2016

What? Chemicals in Implants? Are they SAFE?

What chemicals & what manufacturing procedures were used by PIP in manufacturing fraudulent implants? ANYONE KNOW?

Doctor Brawer in the USA says:

The Australian Regulator (TGA) did some tests on PIP

From TGA Australia

TGA on Cyclic Siloxanes D4, D5, D6

Presence of D4, D5 and D6 siloxanes
AFSSAPS noted that some batches of unauthorised gels contained higher amounts of small silicone molecules (called low molecular weight siloxanes) than the authorised gel. Thus, the TGA is testing the gels to determine the presence of D4, D5 and D6 siloxanes. Test results from GC-MS analyses indicate D4 is present in the gels of PIP breast implants at between 0 and 261ppm, with a median of 136ppm. D5 is present between 0-710ppm, with a median of 434ppm. D5 is present between 0 and 1005, with a median of 470ppm. There does not seem to be any relationship between the year of manufacture of the gel and the presence of D4, D5 and D6 siloxanes. These values could change with the testing of further samples.
Information provided by the suppliers of the raw materials, which were used to produce the gel used in PIP breast implants, together with more recent detailed information provided to the TGA by AFSSAPS, does suggest that the TGA findings are a reasonable estimate of the content of these siloxanes.

The SCENIHR report reproduced this table showing the concentrations of D4, D5 and D6

Published in SCENIHR 

Friday, 31 July 2015

Can EU identify EDC's Staring Them in the Face?

Brussels, 22th of July 2015 

Report on public consultation on defining criteria for identifyingendocrine disruptors in the context of the implementation of the Plant Protection Product Regulation and Biocidal Products Regulation

This consultation was different from other public consultations in that respondents were asked to provide data (for example methodologies used to select endocrine disrupting substances or to identify the socio-economic impact of identified endocrine disruptors). No specific questions were included that asked respondents’ opinions. This report cannot, therefore, provide quantitative information on the views held by different stakeholders. 

"The socio-economic impact of identified endocrine disruptors" limiting jobs for poisoning women and harming children! 

A risk-based approach for regulating endocrine disruptors was proposed by many respondents who identified themselves as farmers, private companies, industrial or trade organisations, or authorities in non-EU countries. Many respondents supported the use of the WHO/IPC 2002 definition as a starting point for defining an endocrine disruptor.  

That's a very interesting figure DG Health & Food Safety ... "Many Respondents" 

EU Priorities for Health


Vytenis Andriukaitis

(2014-2019)Health & Food Safety

Speaking points on priorities for Health - European Policy Centre -

I have already said that on many occasions – a high level of health protection in all EU policies and activities is enshrined in the treaty. What does this mean in practice? For me it means that I need to strive for health to be included in all policy areas. I need to ensure that the Commission puts the health of European citizens first.
I personally made a commitment before the European Parliament to pursue Prevention, Promotion, and Protection in relation to health.

Breast Implants Will Now Carry Cancer Warning In France

Breast Implants Will Now Carry Cancer Warning In France

Following France’s National Cancer Institute finding a “clearly established link” between breast implants and a specific type of cancer, the country will now order all breast implants to come with a cancer warning. This announcement came after 18 cases of anaplastic large cell lymphoma were directly linked to women with silicone breast implants since 2011.

Tuesday, 31 December 2013


PUBLIC CONSULTATION on the preliminary opinion on the 'safety' of Poly Implant Prothèse (PIP) Silicone Breast Implants (2013 update)

The European Commission has launched a public consultation on the above-mentioned preliminary opinion following the Stakeholder Dialogue Procedures (Annex IV to the Rules of Procedurespdf) of the Scientific Committees.

Submission of comments
All interested parties are invited to submit their comments and proposals on the preliminary opinion to the following website.
The deadline for submission of comments is 3 January 2014.

1. In line with the transparency principle outlined in the Rules of Procedurespdf of the Scientific Committees, all submissions and the names of the submitters in response to this public consultation may be made available to the general public via SANCO's website.
2. Only comments submitted in accordance with the Rules of Procedurespdf (Annex IV) will be taken into account.